Skip to Main Content

Paper Details

Developments in the use of tyrosine kinase inhibitors in the treatment of renal cell carcinoma.
Expert Rev Anticancer Ther
5
2019
Author NameAffiliation
Edwin M PosadasCedars-Sinai Medical Center
  • 1 - 1

Datasets

Release 1.2